Doxorubicin
Top View
- North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
- 2019 Table of Drugs
- In Vitro and in Vivo Characterization of Doxorubicin and Vincristine
- Acute Promyelocytic Leukemia Facts
- Liposomal Doxorubicin
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- HOPA News Volume 10, Issue 1
- A Detailed Evaluation of Cardiac Toxicity: a Phase II Study of Doxorubicin and One- Or Three-Hour-Infusion Paclitaxel in Patients with Metastatic Breast Cancer1
- Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory
- In Vivo Evaluation of a Novel Albumin-Binding Prodrug of Doxorubicin in an Orthotopic Mouse Model of Prostate Cancer (Lncap)
- For the Patient: ACT Other Names: BRAJACT
- BRAJACTTG Protocol
- 1 Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor
- Schedule-Dependent Synergism and Antagonism Between Methotrexate
- Mutagenic and Cytotoxic Activity of Doxorubicin and Daunorubicin Derivatives on Prokaryotic and Eukaryotic Cells N
- BC Cancer Protocol Summary for Adjuvant Therapy for Osteosarcoma Using Doxorubicin and Cisplatin
- Do Not Administer Doxorubicin Hcl in Combination with Trastuzumab
- Cisplatin Doxorubicin Sarcoma